| UniProt ID | TOP3B_HUMAN | |
|---|---|---|
| UniProt AC | O95985 | |
| Protein Name | DNA topoisomerase 3-beta-1 | |
| Gene Name | TOP3B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 862 | |
| Subcellular Localization | ||
| Protein Description | Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity.. | |
| Protein Sequence | MKTVLMVAEKPSLAQSIAKILSRGSLSSHKGLNGACSVHEYTGTFAGQPVRFKMTSVCGHVMTLDFLGKYNKWDKVDPAELFSQAPTEKKEANPKLNMVKFLQVEGRGCDYIVLWLDCDKEGENICFEVLDAVLPVMNKAHGGEKTVFRARFSSITDTDICNAMACLGEPDHNEALSVDARQELDLRIGCAFTRFQTKYFQGKYGDLDSSLISFGPCQTPTLGFCVERHDKIQSFKPETYWVLQAKVNTDKDRSLLLDWDRVRVFDREIAQMFLNMTKLEKEAQVEATSRKEKAKQRPLALNTVEMLRVASSSLGMGPQHAMQTAERLYTQGYISYPRTETTHYPENFDLKGSLRQQANHPYWADTVKRLLAEGINRPRKGHDAGDHPPITPMKSATEAELGGDAWRLYEYITRHFIATVSHDCKYLQSTISFRIGPELFTCSGKTVLSPGFTEVMPWQSVPLEESLPTCQRGDAFPVGEVKMLEKQTNPPDYLTEAELITLMEKHGIGTDASIPVHINNICQRNYVTVESGRRLKPTNLGIVLVHGYYKIDAELVLPTIRSAVEKQLNLIAQGKADYRQVLGHTLDVFKRKFHYFVDSIAGMDELMEVSFSPLAATGKPLSRCGKCHRFMKYIQAKPSRLHCSHCDETYTLPQNGTIKLYKELRCPLDDFELVLWSSGSRGKSYPLCPYCYNHPPFRDMKKGMGCNECTHPSCQHSLSMLGIGQCVECESGVLVLDPTSGPKWKVACNKCNVVAHCFENAHRVRVSADTCSVCEAALLDVDFNKAKSPLPGDETQHMGCVFCDPVFQELVELKHAASCHPMHRGGPGRRQGRGRGRARRPPGKPNPRRPKDKMSALAAYFV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MKTVLMVAEK -----CCEEEEEECC | 19.99 | 29083192 | |
| 12 | Phosphorylation | LMVAEKPSLAQSIAK EEEECCHHHHHHHHH | 47.61 | 29083192 | |
| 16 | Phosphorylation | EKPSLAQSIAKILSR CCHHHHHHHHHHHHC | 20.93 | 29083192 | |
| 19 | Ubiquitination | SLAQSIAKILSRGSL HHHHHHHHHHHCCCC | 42.37 | 21890473 | |
| 19 (in isoform 3) | Ubiquitination | - | 42.37 | 21890473 | |
| 19 (in isoform 1) | Ubiquitination | - | 42.37 | 21890473 | |
| 19 (in isoform 2) | Ubiquitination | - | 42.37 | 21890473 | |
| 70 | Phosphorylation | TLDFLGKYNKWDKVD EHHHHCCCCCCCCCC | 21.85 | - | |
| 75 | Ubiquitination | GKYNKWDKVDPAELF CCCCCCCCCCHHHHH | 47.63 | - | |
| 83 | Phosphorylation | VDPAELFSQAPTEKK CCHHHHHHCCCCCCC | 37.75 | 29083192 | |
| 87 | Phosphorylation | ELFSQAPTEKKEANP HHHHCCCCCCCCCCC | 64.55 | 29083192 | |
| 89 | Ubiquitination | FSQAPTEKKEANPKL HHCCCCCCCCCCCCC | 59.39 | - | |
| 95 | Acetylation | EKKEANPKLNMVKFL CCCCCCCCCCEEEEE | 52.91 | 25953088 | |
| 100 (in isoform 2) | Ubiquitination | - | 29.59 | 21890473 | |
| 100 (in isoform 1) | Ubiquitination | - | 29.59 | 21890473 | |
| 100 | Acetylation | NPKLNMVKFLQVEGR CCCCCEEEEEEECCC | 29.59 | 26051181 | |
| 100 (in isoform 3) | Ubiquitination | - | 29.59 | 21890473 | |
| 100 | Ubiquitination | NPKLNMVKFLQVEGR CCCCCEEEEEEECCC | 29.59 | 21890473 | |
| 139 | Ubiquitination | AVLPVMNKAHGGEKT HHHHHHHHHCCCCCE | 24.54 | - | |
| 198 | Ubiquitination | AFTRFQTKYFQGKYG CHHHHHHHHHCCCCC | 33.03 | - | |
| 236 | Acetylation | HDKIQSFKPETYWVL CHHHHHCCCEEEEEE | 47.38 | 26051181 | |
| 254 | Phosphorylation | VNTDKDRSLLLDWDR ECCCCCCCCEECHHH | 33.24 | 29523821 | |
| 281 | Acetylation | LNMTKLEKEAQVEAT HHHHHHHHHHHHHHH | 69.64 | 156179 | |
| 281 | Ubiquitination | LNMTKLEKEAQVEAT HHHHHHHHHHHHHHH | 69.64 | - | |
| 330 | Phosphorylation | QTAERLYTQGYISYP HHHHHHHHCCCCCCC | 21.80 | 28152594 | |
| 333 | Phosphorylation | ERLYTQGYISYPRTE HHHHHCCCCCCCCCC | 4.11 | 23663014 | |
| 335 | Phosphorylation | LYTQGYISYPRTETT HHHCCCCCCCCCCCC | 22.17 | 28152594 | |
| 336 | Phosphorylation | YTQGYISYPRTETTH HHCCCCCCCCCCCCC | 6.28 | 28152594 | |
| 351 (in isoform 2) | Ubiquitination | - | 48.58 | 21890473 | |
| 351 (in isoform 1) | Ubiquitination | - | 48.58 | 21890473 | |
| 351 (in isoform 3) | Ubiquitination | - | 48.58 | 21890473 | |
| 351 | Ubiquitination | YPENFDLKGSLRQQA CCCCCCCCCHHHHHC | 48.58 | 2190698 | |
| 430 | Phosphorylation | DCKYLQSTISFRIGP CCCHHCCEEEEEECC | 14.00 | 23927012 | |
| 432 | Phosphorylation | KYLQSTISFRIGPEL CHHCCEEEEEECCCC | 14.46 | 29496963 | |
| 501 | Phosphorylation | LTEAELITLMEKHGI CCHHHHHHHHHHCCC | 32.45 | - | |
| 526 | Phosphorylation | NNICQRNYVTVESGR HCCCCCCCEEECCCC | 10.33 | 29496907 | |
| 566 | Ubiquitination | TIRSAVEKQLNLIAQ HHHHHHHHHHHHHHH | 54.19 | - | |
| 590 | Acetylation | GHTLDVFKRKFHYFV HHHHHHHHHHHHHHH | 55.30 | 25953088 | |
| 633 | Phosphorylation | KCHRFMKYIQAKPSR HHHHHHHHHHCCCCC | 6.10 | 28634120 | |
| 637 | Ubiquitination | FMKYIQAKPSRLHCS HHHHHHCCCCCEEEC | 27.44 | - | |
| 639 | Phosphorylation | KYIQAKPSRLHCSHC HHHHCCCCCEEECCC | 46.93 | 28634120 | |
| 644 | Phosphorylation | KPSRLHCSHCDETYT CCCCEEECCCCCEEE | 19.19 | 28634120 | |
| 657 | Phosphorylation | YTLPQNGTIKLYKEL EECCCCCEEEEEEEE | 23.61 | 28634120 | |
| 662 | Acetylation | NGTIKLYKELRCPLD CCEEEEEEEECCCCC | 61.79 | 26051181 | |
| 677 | Phosphorylation | DFELVLWSSGSRGKS CCEEEEEECCCCCCC | 22.21 | 27174698 | |
| 678 | Phosphorylation | FELVLWSSGSRGKSY CEEEEEECCCCCCCC | 29.25 | 27174698 | |
| 680 | Phosphorylation | LVLWSSGSRGKSYPL EEEEECCCCCCCCCC | 39.55 | 27174698 | |
| 772 | Phosphorylation | RVSADTCSVCEAALL EECCCCCHHHHHHHC | 31.71 | 27251275 | |
| 788 | Phosphorylation | VDFNKAKSPLPGDET CCCCCCCCCCCCCCC | 36.21 | 25159151 | |
| 824 | Methylation | ASCHPMHRGGPGRRQ HHCCCCCCCCCCCCC | 45.58 | 115384017 | |
| 829 | Methylation | MHRGGPGRRQGRGRG CCCCCCCCCCCCCCC | 30.77 | 115918741 | |
| 853 | Ubiquitination | NPRRPKDKMSALAAY CCCCCHHHHHHHHHH | 40.66 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOP3B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOP3B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOP3B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RSMB_HUMAN | SNRPB | physical | 11549288 | |
| CENPF_HUMAN | CENPF | physical | 11549288 | |
| CHD8_HUMAN | CHD8 | physical | 11549288 | |
| CHIC2_HUMAN | CHIC2 | physical | 16189514 | |
| KR412_HUMAN | KRTAP4-12 | physical | 16189514 | |
| FBLN5_HUMAN | FBLN5 | physical | 11549288 | |
| GRN_HUMAN | GRN | physical | 11549288 | |
| PNMA2_HUMAN | PNMA2 | physical | 25416956 | |
| TRIM1_HUMAN | MID2 | physical | 25416956 | |
| ATL4_HUMAN | ADAMTSL4 | physical | 25416956 | |
| TRI41_HUMAN | TRIM41 | physical | 25416956 | |
| ADIP_HUMAN | SSX2IP | physical | 25416956 | |
| SPRE2_HUMAN | SPRED2 | physical | 25416956 | |
| TDRD3_HUMAN | TDRD3 | physical | 26344197 | |
| TDRD3_HUMAN | TDRD3 | physical | 28101374 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...